Skip to content
myglp1coverage.com

Maryland Medicaid · Osa

Maryland Medicaid coverage for Zepbound (Osa)

Medicaid

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • Prescribed by or in consultation with a specialist
  • Diagnosed obstructive sleep apnea (AHI of 15 or higher)

Qualification pathways

You can qualify through any one of these.

OSA Initial Approval

All of:

  • Age >= 18 years
  • BMI >= 30 kg/m2
  • Moderate to severe OSA diagnosed by polysomnography or home sleep study with AHI >= 15 events per hour
  • Prescribed by or in consultation with a sleep specialist, pulmonologist, or other provider experienced in treating OSA
  • Current height and weight measurements within the last 90 days
  • Patient meets FDA-approved prescribing information clinical parameters (no contraindications, appropriate screening and monitoring completed)
  • Will not be used concurrently with other tirzepatide-containing products or GLP-1 receptor agonists

Documentation to bring

  • Prescription from or documentation of consultation with a sleep specialist, pulmonologist, or other provider experienced in treating OSA
  • Polysomnography or home sleep study results showing AHI >= 15 events per hour
  • Current height and weight measurements within the last 90 days confirming BMI >= 30 kg/m2
  • Prescriber attestation that patient meets FDA-approved prescribing information clinical parameters (no contraindications, appropriate screening and monitoring)

Quantity limits

  • any strength — 4 pens/28 days

Approval and renewal

  • Initial approval: 6 months
  • Renewal: every 6 months
  • To renew, the plan looks for Prescriber attestation of continued clinical benefit and subsequent evaluation and monitoring performed. BMI must remain >= 30 kg/m2. After 12 months, repeat documentation via polysomnography, sleep study, or CPAP data confirming moderate to severe OSA is required, and annually thereafter.

Not covered when

  • Concurrent use of other tirzepatide-containing products
  • Concurrent use of GLP-1 receptor agonists
  • BMI < 30 kg/m2 (renewal denial)

Policy note: Therapy beyond 12 months requires repeat documentation (via polysomnography, sleep study, or CPAP data) confirming moderate to severe OSA, and annually thereafter. Renewal will NOT be authorized if BMI < 30 kg/m2.

verified June 4, 2026 · source: policy-368.html

All Zepbound policies under Maryland Medicaid · Check your card